Clinical trials
Leukemia, Lymphocytic, Chronic, B-Cell trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 7 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The First Affiliated Hospital with Nanjing Medical University | 4 |
| Chinese PLA General Hospital | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| Chongqing Precision Biotech Co., Ltd | 2 |
| Kai Lin Xu; Jun Nian Zheng | 2 |
| Shenzhen Second People's Hospital | 2 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Centaurus Biopharma Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 35 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Lymphoma, Follicular | 9 |
| Lymphoma, Mantle-Cell | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Lymphoma, B-Cell | 8 |
| Hematologic Neoplasms | 5 |
| Lymphoma | 5 |
| Leukemia | 4 |
| Leukemia, Prolymphocytic | 3 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.